Folgen
Lisa Butler
Lisa Butler
University of Adelaide
Bestätigte E-Mail-Adresse bei adelaide.edu.au - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
LM Butler, DB Agus, HI Scher, B Higgins, A Rose, C Cordon-Cardo, ...
Cancer research 60 (18), 5165-5170, 2000
8342000
The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin
LM Butler, X Zhou, WS Xu, HI Scher, RA Rifkind, PA Marks, VM Richon
Proceedings of the National Academy of Sciences 99 (18), 11700-11705, 2002
6632002
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
LM Butler, Y Perone, J Dehairs, LE Lupien, V de Laat, A Talebi, M Loda, ...
Advanced drug delivery reviews 159, 245-293, 2020
4872020
Dual roles of PARP-1 promote cancer growth and progression
MJ Schiewer, JF Goodwin, S Han, JC Brenner, MA Augello, JL Dean, ...
Cancer discovery 2 (12), 1134-1149, 2012
4862012
Androgen receptor inhibits estrogen receptor-α activity and is prognostic in breast cancer
AA Peters, G Buchanan, C Ricciardelli, T Bianco-Miotto, MM Centenera, ...
Cancer research 69 (15), 6131-6140, 2009
4732009
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer
HI Scher, G Buchanan, W Gerald, LM Butler, WD Tilley
Endocrine-related cancer 11 (3), 459-476, 2004
3102004
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer
G Zadra, CF Ribeiro, P Chetta, Y Ho, S Cacciatore, X Gao, S Syamala, ...
Proceedings of the National Academy of Sciences 116 (2), 631-640, 2019
2602019
Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors
JL Dean, AK McClendon, TE Hickey, LM Butler, WD Tilley, AK Witkiewicz, ...
Cell cycle 11 (14), 2756-2761, 2012
2562012
Tumour fatty acid metabolism in the context of therapy resistance and obesity
AJ Hoy, SR Nagarajan, LM Butler
Nature Reviews Cancer 21 (12), 753-766, 2021
2472021
Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease
LA Selth, S Townley, JL Gillis, AM Ochnik, K Murti, RJ Macfarlane, KN Chi, ...
International journal of cancer 131 (3), 652-661, 2012
2462012
Maximizing the therapeutic potential of HSP90 inhibitors
LM Butler, R Ferraldeschi, HK Armstrong, MM Centenera, P Workman
Molecular cancer research 13 (11), 1445-1451, 2015
2402015
Cancer-associated fibroblasts—heroes or villains?
KA Gieniec, LM Butler, DL Worthley, SL Woods
British journal of cancer 121 (4), 293-302, 2019
2242019
The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid
DC Coffey, MC Kutko, RD Glick, LM Butler, G Heller, RA Rifkind, PA Marks, ...
Cancer research 61 (9), 3591-3594, 2001
2092001
Minireview: the contribution of different androgen receptor domains to receptor dimerization and signaling
MM Centenera, JM Harris, WD Tilley, LM Butler
Molecular endocrinology 22 (11), 2373-2382, 2008
1992008
Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development
T Bianco-Miotto, K Chiam, G Buchanan, S Jindal, TK Day, M Thomas, ...
Cancer epidemiology, biomarkers & prévention 19 (10), 2611-2622, 2010
1962010
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
LM Butler, Y Webb, DB Agus, B Higgins, TR Tolentino, MC Kutko, ...
Clinical cancer research 7 (4), 962-970, 2001
1792001
Peptidomimetic targeting of critical androgen receptor–coregulator interactions in prostate cancer
P Ravindranathan, TK Lee, L Yang, MM Centenera, L Butler, WD Tilley, ...
Nature communications 4 (1), 1923, 2013
1662013
Ex vivo culture of human prostate tissue and drug development
MM Centenera, GV Raj, KE Knudsen, WD Tilley, LM Butler
Nature Reviews Urology 10 (8), 483-487, 2013
1572013
The diversity and breadth of cancer cell fatty acid metabolism
SR Nagarajan, LM Butler, AJ Hoy
Cancer & Metabolism 9 (1), 2, 2021
1542021
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis
ZD Nassar, CY Mah, J Dehairs, IJG Burvenich, S Irani, MM Centenera, ...
Elife 9, e54166, 2020
1462020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20